Trials begin in UK on new vaccine to fight Covid-19 variants

The trial, which began this morning in Manchester, is expected to recruit 20 more volunteers, with results expected early next year

Helen Clarke, the first woman to take part in the new trial. Picture: PA

Trials are underway in the UK of a new jab to fight Covid-19 variants in the hope it can offer longer-lasting immunity than current vaccines.

Initially involving participants aged 60 and over, its creators hope the new drug – GRT-R910 – can boost the immune response of first-generation Covid-19 vaccines to a wide array of variants of Sars-Cov-2, which cause Covid-19.